Immunomodulatory drugs in multiple myeloma: Impact of the SCARMET (Self CARe and MEdication Toxicity) educational intervention on outpatients' knowledge to manage adverse effects.
Périchou J, Ranchon F, Herledan C, Huot L, Larbre V, Carpentier I, Lazareth A, Karlin L, Beny K, Vantard N, Schwiertz V, Caffin AG, Baudouin A, Sesques P, Brisou G, Ghesquières H, Salles G, Rioufol C.
Périchou J, et al. Among authors: carpentier i.
PLoS One. 2020 Dec 4;15(12):e0243309. doi: 10.1371/journal.pone.0243309. eCollection 2020.
PLoS One. 2020.
PMID: 33275634
Free PMC article.
Clinical Trial.